Part I. Evaluation of the Overweight or Obese Patient

• Classification and Evaluation of the Overweight Patient
  George A. Bray
• Waist Girth: A Critical Evaluation of Usefulness
  Marie-France Hivert and James B. Meigs
• Genetic Evaluation of Obese Patients
  I. Sadaf Farooqi and Stephen O’Rahilly
• Cultural Differences as Influences on Approaches to Obesity Treatment
  Shiriki Kumanyika
• Bias, Discrimination, and Obesity
  Rebecca M. Puhl and Kelly D. Brownell
• Impact of Voluntary Weight Loss on Morbidity and Mortality
  Edward W. Gregg
• Weight Cycling as an Instance of False Hope
  Janet Polivy and C. Peter Herman
• Obesity and the Primary Care Physician
  Robert F. Kushner and Louis J. Aronne

Part II. Prevention of Obesity

• The Prevention of Obesity in Childhood and Adolescence
  Tim Lobstein
• Prevention of Obesity
  W. Philip T. James and Timothy P. Gill
• Analyzing and Influencing Obesogenic Environments
  Boyd Swinburn and Garry Egger
• Reengineering the Built Environment: Schools, Worksites, Neighborhoods, and Parks
  Deborah A. Cohen
• Agriculture and the Food Industry’s Role in America’s Weight Pandemic
  James E. Tillotson

Part III. Medical Management of Obesity

• Behavioral Approaches to the Treatment of Obesity
  Rena R. Wing
• Preventing Weight Regain After Weight Loss
  Michael G. Perri, John P. Foreyt, and Stephen D. Anton
• Diet Composition and Weight Loss
  Angela P. Makris, Gary D. Foster, and Arne Astrup
• Exercise and Weight Management
  Tim Church
• Sibutramine in the Management of Obesity
  Donna H. Ryan
• Drugs That Modify Fat Absorption and Alter Metabolism
  George A. Bray and Luc F. Van Gaal
• Cannabinoid Receptor Antagonists as Potential Antiobesity Agents
  George A. Bray
• Integrated Neurohormonal Approach to the Treatment of Obesity: The Amylin Agonist Pramlintide and Its Interactions with Leptin and PYY Signaling Pathways
  Jonathan D. Roth, Christine Mack, Nicole C. Kesty, David G. Parkes, and Christian Weyer
• Neuropeptide Y in the Management of Obesity
  Ira Gantz and Ngozi E. Erondu
• Serotonin Receptor Modulation in the Treatment of Obesity
  Jason C.G. Halford and John E. Blundell
• Melanocortin-4 Receptor as a New Target for Drug Development
  Tung M. Fong and Alison Strack
• Histamine H3 Receptor Antagonists in the Treatment of Obesity
  Karin Rimvall, Rolf Hohlweg, and Kjell Malmlöof
• Drugs with Thermogenic Properties
  Arne Astrup and Søren Toubro
• Strategies to Reduce Calories in Food
  Alexandra G. Kazaks and Judith S. Stern
• Herbal and Alternative Approaches to Obesity
  Frank Greenway and David Heber
• Is There a Future for Gene Therapy in Obesity?
  Sergei Zolotukhin
• Prevention and Management of Dyslipidemia and the Metabolic Syndrome in Obese Patients
  Scott M. Grundy

Part IV. Surgery

• Surgical Treatment and Comorbidities
  Henry Buchwald
• Swedish Obese Subjects: A Review of Results from a Prospective Controlled Intervention Trial
  Lars Sjöström
• Laparoscopic Adjustable Gastric Banding
  Paul E. O’Brien
• Evolving Surgical Therapy for Obesity
  Michael J. Barker and Walter J. Pories
• Liposuction and Obesity
  Luigi Fontana and Samuel Klein

Part V. Special Issues

• Obesity and Binge Eating Disorder
  Janet D. Latner and G. Terence Wilson
• Special Issues in Treatment of Pediatric Obesity
  Robert E. Kramer and Stephen R. Daniels
• Weight Loss Clinics: Range of Capabilities, Benefits, Risks, and Costs
  Ken Fujioka
• Economic Aspects of Obesity
  Ping Zhang and Rui Li
• Government’s Evolving Role: Nutrition, Education, Regulation, Monitoring, and Research
  Catherine E. Woteki, Samira S. Jones, and M.R.C. Greenwood

• George A. Bray, Louisiana State University, Baton Rouge, Louisiana, USA
  George A. Brayis a former Executive Director (1989-1999) and current Boyd Professor at the Pennington Biomedical Research Center in Baton Rouge, Louisiana, as well as Professor of Medicine at the LSU Health Sciences Center in New Orleans, Louisiana. Dr. Bray received his A.B. in Chemistry from Brown University, Providence, Rhode Island, and his M.D. from Harvard Medical School, Boston, Massachusetts. He has served with NIH, the Department of Health, Education and Welfare, and WHO. His research interests include dietary, nutritional, and pharmacological treatment of diabetes and obesity.
• Claude Bouchard, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA
  Claude Bouchardis the Executive Director of the Pennington Biomedical Research Center and holds the George A. Bray Chair in Nutrition. He holds a B.Ped. (Laval), a M.Sc. (University of Oregon, Eugene) in exercise physiology and a Ph.D. (University of Texas, Austin) in population genetics. His research deals with the genetics of adaptation to exercise and to nutritional interventions as well as the genetics of obesity and its co-morbidities. Prior to coming to Pennington, he held the Donald B. Brown Research Chair on Obesity at Laval University where he was the Director of the Physical Activity Sciences Laboratory for about 20 years. His research has been funded mainly by the National Institutes of Health.